G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 58.8 NOK 3.16% Market Closed
Market Cap: 906.7m NOK

Operating Margin

13.4%
Current
Improving
by 15.2%
vs 3-y average of -1.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
13.4%
=
Operating Income
kr23.2m
/
Revenue
kr172.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
13.4%
=
Operating Income
kr23.2m
/
Revenue
kr172.5m

Peer Comparison

Country Company Market Cap Operating
Margin
NO
Gentian Diagnostics ASA
OSE:GENT
906.8m NOK
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
31.7B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
34.9B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
123.7B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
44.6B CNY
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6.1B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD
Loading...
No Stocks Found

Market Distribution

Higher than 85% of companies in Norway
Percentile
85th
Based on 890 companies
85th percentile
13.4%
Low
-3 055 100% — -3.7%
Typical Range
-3.7% — 6.8%
High
6.8% — 784.1%
Distribution Statistics
Norway
Min -3 055 100%
30th Percentile -3.7%
Median 1.8%
70th Percentile 6.8%
Max 784.1%

Gentian Diagnostics ASA
Glance View

Market Cap
906.7m NOK
Industry
Health Care

Gentian Diagnostics ASA is a medical diagnostics company. The company is headquartered in Moss, Ostfold. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.

GENT Intrinsic Value
52.6 NOK
Overvaluation 11%
Intrinsic Value
Price
G
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
13.4%
=
Operating Income
kr23.2m
/
Revenue
kr172.5m
What is Gentian Diagnostics ASA's current Operating Margin?

The current Operating Margin for Gentian Diagnostics ASA is 13.4%, which is above its 3-year median of -1.8%.

How has Operating Margin changed over time?

Over the last 3 years, Gentian Diagnostics ASA’s Operating Margin has increased from -29.8% to 13.4%. During this period, it reached a low of -29.8% on Sep 30, 2022 and a high of 15.7% on Mar 31, 2025.

Back to Top